Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
SYNERGY PHARMA (NQ: SGYP)
5.160 USD  +0.050 (+0.98%)
Streaming Delayed Price  /  Updated: 4:00 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Stories about SYNERGY PHARMA
 
< Previous 1 2 Next >
Bio-Wire Weekly: April 22 – April 26, 2013
April 29, 2013
Bio-Wire Weekly: April 22 – April 26, 2013 Good morning. Please sit, have a cup of coffee (or tea), and let’s go over last week’s action in the biotech & small pharma sector Note: get the weekly... Read More
category THRX , SRPT , CELG , and 9 more.
from Bio-Wire.Com
Synergy Pharmaceuticals Becomes Oversold (SGYP)
April 23, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Synergy Pharma Reports Completion of Public Offering of Shares, Received Net Proceeds $84.5M
April 16, 2013
Synergy Pharmaceuticals Inc.(Nasdaq: SGYP ), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten public offering of 16,375,000 shares of... Read More
category Benzinga , Offerings , News , and 1 more.
from Latest Articles from Benzinga.com
Synergy Prices Offering At Discount
April 11, 2013
Synergy Pharmaceuticals Inc. (NYSE: SGYP) priced its public offering of 16.375 million common shares at the discounted price of $5.50 per share sending the stock price down 69 cents to close at... Read More
from MarketMinute.com Stock News
Unusual 11 Mid-Day Movers 04/11: (ACAD) (STP) (RAD) Higher; (NTIC) (LEDS) (FTNT) Lower
April 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8248312 for the full story. Read More
from StreetInsider.com News Articles
Markets Advance As Jobless Claims Tumble
April 11, 2013
The markets advanced during the midday with the Dow gaining 57 points to 14,859 as jobless claims tumbled more than expected. Nasdaq held steady at 3297. Read More
category Market News
from MarketMinute.com Market Updates
StreetInsider.com Pre-Open Movers 4/11: (ACAD) (AMRS) (RAD) Higher; (FTNT) (HPQ) (MSFT) Lower (more...)
April 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8247489 for the full story. Read More
from StreetInsider.com News Articles
Synergy Pharmaceuticals (SGYP) Prices 16.375M Shares at $5.50/Sh
April 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8247459 for the full story. Read More
from StreetInsider.com News Articles
BRIEF-Synergy Pharmaceuticals shares off 6 pct premarket
April 11, 2013
NEW YORK, April 11 (Reuters) - Synergy Pharmaceuticals Inc : * Shares off 6 percent premarket after pricing of stock offering Read More
category companyNews
from Reuters: Company News
Synergy Pharmaceuticals Prices 16.375M Share Public Offering at $5.50/Share
April 10, 2013
Synergy Pharmaceuticals (NASDAQ: SGYP ) today announced the pricing of an underwritten public offering of 16,375,000 shares of its common stock. The gross proceeds to Synergy from this offering are... Read More
category Earnings , Benzinga , Guidance , and 2 more.
from Latest Articles from Benzinga.com
Sharply Higher Close On Strong Chinese Trade Data
April 10, 2013
The markets soared to close sharply higher with the Dow leaping 128 points to 14,802 over strong March trade data from China. Nasdaq surged 59 points to 3297. Read More
category Market News
from MarketMinute.com Market Updates
Market Wrap for Wednesday, April 10: Dow and S&P Close at New Record Highs as Rally Sweeps Wall Street
April 10, 2013
Wednesday's FOMC minutes showed that despite some dissent, the Federal Reserve is set to press on with its $85 billion-per-month asset purchase program. The continuation of the Fed's dovish monetary... Read More
category TITN , Earnings , Benzinga , and 28 more.
from Latest Articles from Benzinga.com
Unusual 11 Mid-Day Movers 04/10: (IFMI) (DRWI) (STP) Higher; (HMA) (TITN) (HBIO) Lower
April 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8245433 for the full story. Read More
from StreetInsider.com News Articles
MARKET PULSE- Health Management, Titan Machinery, BioLineRx, JinkoSolar
April 10, 2013
April 10 (Reuters) - Some U.S. stocks on the move on Wednesday: Read More
category companyNews
from Reuters: Company News
StreetInsider.com Pre-Open Movers 4/10: (WOR) (YHOO) (FB) Higher; (TITN) (HMA) (FSLR) Lower (more...)
April 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8244546 for the full story. Read More
from StreetInsider.com News Articles
MARKET PULSE- Hospital operators, Titan Machinery, Adtran, Suntech
April 10, 2013
April 10 (Reuters) - Some U.S. stocks to watch on Wednesday: Read More
category companyNews
from Reuters: Company News
Streetinsider.com After-Hours Movers 4/09: (WOR) (PSMT) Higher; (HMA) (RLGY) (THC) Lower (more...)
April 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8243249 for the full story. Read More
from StreetInsider.com News Articles
Synergy Pharma (SGYP) Announces $90M Common Offering
April 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8242928 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Cantor Fitzgerald Lowers PT on Synergy Pharmaceuticals; Stating Dilution
March 19, 2013
Cantor Fitzgerald analyst Adeyemi Ogunkoya published a report on Synergy Parmaceuticals (NASDAQ: SGYP ) that lowered the price target from $13 to $12 and maintained a Buy rating stating... Read More
category Cantor Fitzgerald , Benzinga , Price Target , and 3 more.
from Latest Articles from Benzinga.com
UPDATE: Cantor Fitzgerald Reiterates Synergy Pharmaceuticals at Buy on Late Breaker Announcement
March 15, 2013
In a report published by Cantor Fitzgerald, analyst Irina Rivkind reiterated a Buy rating and $13 price target on Synergy Pharmaceuticals (NASDAQ: SGYP ). Cantor Fitzgerald reported that, “DDW Late... Read More
category Reiteration , Benzinga , Canter Fitzgerald , and 3 more.
from Latest Articles from Benzinga.com
Synergy Pharmaceuticals Inc Enters Oversold Territory (SGYP)
February 27, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Friday 2/1 Insider Buying Report: SGYP, MCP
February 01, 2013
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. Read More
category Stocks
from Market News Video
The Life Sciences Report Watchlist 2013
February 01, 2013
category Pharmaceuticals
from Trefis
Synergy Pharmaceuticals Shareholders Approve Merger with Callisto Pharmaceuticals
January 15, 2013
Synergy Pharmaceuticals (NASDAQ: SGYP ) ("Synergy") today announced that it convened its annual meeting of stockholders yesterday and it has received the necessary approvals from its stockholders to... Read More
category Management , Benzinga , Guidance , and 5 more.
from Latest Articles from Benzinga.com
Stocks Soar on Fiscal Cliff Deal; Dow Climbs More Than 300 Points
January 02, 2013
The U.S. stock market surged on Wednesday as lawmakers reached a last minute agreement to avert the fiscal cliff. Investors who had been concerned about the immediate effects to the economy if a deal... Read More
category US59156R1086 , US0537741052 , Benzinga , and 30 more.
from Latest Articles from Benzinga.com
UPDATE: Cantor Fitzgerald Raises PT to $13 on Synergy Pharmaceuticals on Positive Data
January 02, 2013
Cantor Fitzgerald reiterated its Buy rating on Synergy Pharmaceuticals (NASDAQ: SGYP ) and increased its price target from $7 to $13. Cantor Fitzgerald commented, "Positive data announcement is a key... Read More
category Benzinga , Price Target , Cantor Fitzgerald , and 5 more.
from Latest Articles from Benzinga.com
UPDATE: Canaccord Genuity Raises PT to $10 on Synergy Pharmaceuticals on Positive Plecanatide Data
January 02, 2013
Canaccord Genuity reiterated its Buy rating on Synergy Pharmaceuticals (NASDAQ: SGYP ) and increased its price target from $7 to $10. Canaccord Genuity noted, "Reiterate BUY, raise target to $10 on... Read More
category Canaccord Genuity , Benzinga , Price Target , and 5 more.
from Latest Articles from Benzinga.com
Unusual 11 Mid-Day Movers 01/02: (ZIP) (BIOF) (STXS) Higher; (SKUL) (DOLE) (NTLS) Lower
January 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7976928 for the full story. Read More
from StreetInsider.com News Articles
Markets Surge On Fiscal Cliff Deal
January 02, 2013
The last minute passage of a fiscal cliff deal boosted the markets during the midday with the Dow leaping 226 points to 13,330. Nasdaq surged 67 points to 3087. Read More
category Market News
from MarketMinute.com Market Updates
Synergy Pharmaceuticals (SGYP) PT Nearly Doubled at Cantor Fitzgerald
January 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7976853 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here